Q3 2024 · 13F-HR
Rosalind Advisors, Inc.holdings as filed
Filed 2024-10-30 · accession 0001622627-24-000058
$156.2M
Reported value
33
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 24661P807 | DCTH | DELCATH SYSTEMS, INC. | $21.2M | 13.6% | 2,650,389 | Common | SOLE |
| 62857J201 | MYO | MYOMO INC | $12.1M | 7.76% | 3,021,391 | Common | SOLE |
| 21900C308 | CRMD | CORMEDIX INC | $11.9M | 7.63% | 1,475,000 | Common | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS-NEW | $11.6M | 7.41% | 1,832,000 | Common | SOLE |
| M68830112 | MDWD | MEDIWOUND LTD | $11.3M | 7.26% | 628,050 | Common | SOLE |
| 23256X100 | — | CYBIN INC | $9.6M | 6.12% | 1,075,105 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HLDGS INC | $8.8M | 5.67% | 3,104,995 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $7.9M | 5.07% | 275,000 | Common | SOLE |
| 15117F807 | CLRBUSD | CELLECTAR BIOSCIENCES INC | $7.9M | 5.03% | 3,671,550 | Common | SOLE |
| 67576A100 | OCUL | Ocular Therapeutix, Inc | $7.7M | 4.93% | 885,000 | Common | SOLE |
| 45779A846 | NSPR | INSPIREMD INC | $6.7M | 4.31% | 2,514,046 | Common | SOLE |
| 68404V100 | — | OPTINOSE INC | $5.6M | 3.55% | 8,287,503 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $4.9M | 3.15% | 781,423 | Common | SOLE |
| 74319B502 | PROF | PROFOUND MEDICAL CORP | $3.9M | 2.48% | 485,973 | Common | SOLE |
| 21900C908 | — | CORMEDIX INC | $3.6M | 2.33% | 700,000 | CALL | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $3.5M | 2.25% | 303,864 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $2.5M | 1.60% | 750,000 | Common | SOLE |
| 69012T206 | ONSGBP | OUTLOOK THERAPEUTICS INC | $2.4M | 1.54% | 450,000 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $2.3M | 1.50% | 679,168 | Common | SOLE |
| 92536C103 | VERUEUR | VERU INC | $2.1M | 1.33% | 2,694,503 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $1.6M | 1.03% | 139,983 | Common | SOLE |
| 14817C957 | — | CASSAVA SCIENCES INC | $1.5M | 0.93% | 367,400 | PUT | SOLE |
| 69120X206 | OWLT | OWLET INC | $1.2M | 0.78% | 270,000 | Common | SOLE |
| 49721T309 | EYEGEUR | KIORA PHARMACEUTICALS INC | $935,331 | 0.60% | 255,555 | Common | SOLE |
| 34960Q307 | FBIO | FORTRESS BIOTECH INC-NEW | $726,586 | 0.47% | 502,828 | Common | SOLE |
| 09077D209 | BFRI | BIOFRONTERA INC | $659,002 | 0.42% | 495,490 | Common | SOLE |
| 00444T209 | TLPH | TALPHERA INC | $650,130 | 0.42% | 758,966 | Common | SOLE |
| 48115J109 | DERM | JOURNEY MEDICAL CORP | $598,431 | 0.38% | 105,917 | Common | SOLE |
| 46090E103 | QQQ | INVESCO QQQ TR | $220,500 | 0.14% | 150,000 | PUT | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA CO NV | $168,042 | 0.11% | 10,123 | Common | SOLE |
| 78464A870 | XBI | SPDR SER TR | $164,000 | 0.10% | 200,000 | PUT | SOLE |
| 185063104 | CLSDUSD | CLEARSIDE BIOMEDICAL INC | $161,569 | 0.10% | 127,220 | Common | SOLE |
| 929033108 | — | VOR BIOPHARMA INC | $53,680 | 0.03% | 76,685 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.